NasdaqCM - Nasdaq Real Time Price USD
Celularity Inc. (CELU)
1.6100
+0.1300
+(8.78%)
At close: April 23 at 4:00:01 PM EDT
1.6400
+0.03
+(1.86%)
After hours: April 23 at 7:59:12 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 12.5M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BRIGIDO STEPHEN Officer | -- | Direct | -- | Apr 11, 2025 |
| HARIRI ROBERT J Chief Executive Officer | -- | Direct | -- | Apr 11, 2025 |
| BEERS DAVID C Chief Financial Officer | -- | Direct | -- | Apr 11, 2025 |
| HAINES JOHN R. Officer | -- | Direct | -- | Apr 11, 2025 |
| BRIGIDO STEPHEN Officer | -- | Direct | -- | Feb 14, 2025 |
| BEERS DAVID C Chief Financial Officer | -- | Direct | -- | Feb 14, 2025 |
| HAINES JOHN R. Officer | -- | Direct | -- | Feb 14, 2025 |
| LIM KOK THAY Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 2.07 per share. | Indirect | 2,459,688 | Jan 24, 2025 |
| KEHLER DEAN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 19, 2024 |
| PARKS DIANE L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 19, 2024 |
| BERMAN RICHARD JAY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 19, 2024 |
| DIAMANDIS PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 19, 2024 |
| DIAMANDIS PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 19, 2024 |
| LING GEOFFREY M. D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 19, 2024 |
| LIM KOK THAY Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.25 per share. | Indirect | 5,331,335 | Jan 12, 2024 |
| SORRENTO THERAPEUTICS, INC. Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Oct 5, 2023 |
| HARIRI ROBERT J Chief Executive Officer | Purchase at price 0.16 - 0.17 per share. | Direct | 2,984,294 | Oct 5, 2023 |
| KILCOYNE ADRIAN Officer | -- | Direct | -- | Jul 14, 2023 |
| KEHLER DEAN C Director | -- | Direct | -- | Jun 14, 2023 |
| SCULLEY JOHNIII Director | -- | Direct | -- | Jun 14, 2023 |
| PARKS DIANE L. Director | -- | Direct | -- | Jun 14, 2023 |
| MAZUR MARC B Director | -- | Direct | -- | Jun 14, 2023 |
| DIAMANDIS PETER Director | -- | Direct | -- | Jun 14, 2023 |
| VON ESCHENBACH ANDREW CHARLES Director | -- | Direct | -- | Jun 14, 2023 |
| SMITH ROBIN L Director | -- | Direct | -- | Jun 14, 2023 |
| LIM KOK THAY Director | -- | Direct | -- | Jun 14, 2023 |
Related Tickers
TENX Tenax Therapeutics, Inc.
5.46
+7.06%
APLM Apollomics, Inc.
6.19
+7.47%
COEP Coeptis Therapeutics Holdings, Inc.
11.50
-0.09%
SRNE Sorrento Therapeutics, Inc.
0.0009
0.00%
AARD Aardvark Therapeutics, Inc. Common Stock
8.52
+11.23%
PRAX Praxis Precision Medicines, Inc.
36.59
+1.70%
EDSA Edesa Biotech, Inc.
2.3300
+1.30%
CANF Can-Fite BioPharma Ltd.
1.1800
+0.85%
GNLX Genelux Corporation
2.9000
-1.36%
TCBPY TC Biopharm (Holdings) Plc
0.3100
-6.06%